Surgical Management of Thick Primary Cutaneous Melanoma in the US
Cancer Medicine · 2025
DOI: 10.1002/cam4.70578 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2025. Verfasst von Arthur W Cowman und 6 weiteren Autor:innen. Beteiligte Einrichtung: Saint John's Cancer Institute, Santa Monica, California, USA. Hauptthemen laut MEDLINE: Melanoma, Skin Neoplasms, Lymph Node Excision. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: John Wayne Cancer Foundation, Borstein Family Foundation.
Abstract (Originalsprache)
Background
There remains significant variability in the surgical management of thick melanoma patients with clinically node‐negative disease. We evaluated factors influencing overall survival (OS) in these patients, focusing on the surgical management of the primary tumor and nodal basin.
Methods
Using the National Cancer Database, we identified 7647 patients diagnosed between 2012 and 2017 with thick melanoma (> 4 mm, T4) and clinically node‐negative disease. 4332 patients had complete data and met all inclusion criteria. These patients were stratified into three groups based on nodal assessment: sentinel lymph node biopsy (SLNB), elective lymphadenectomy (ELND), or no nodal evaluation (NNE). OS was compared using Kaplan–Meier analyses and multivariable Cox proportional hazard regression.
Results
In the cohort, 2851 (65.8%) had a SLNB, 799 (18.4%) had an ELND, and 682 (15.7%) had NNE. OS significantly decreased for each millimeter of increasing Breslow thickness. Ulceration, lymphovascular invasion, and tumor‐positive SLN (+SLN) were associated with worse OS (all p < 0.001). The size of surgical margins was not significantly associated with OS. Five‐year OS of patients with SLNB was 67.1% ± 1.2% compared to 57.9% ± 2.3% with ELND and 46.8% ± 2.5% with NNE ( p < 0.001). Among +SLN patients, a complete lymph node dissection (CLND) was performed in 400 (62.3%) but was not associated with improved OS ( p = 0.67) when compared to the nodal observation group.
Conclusion
Our results suggest that increasing Breslow thickness and nodal assessment provide important prognostic information regarding OS for thick melanoma patients, which emphasizes the importance of SLNB for staging and confirm the lack of benefit of CLND after +SLN in thick melanoma. The size of surgical margins did not affect OS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Saint John's Cancer Institute, Santa Monica, California, USA.
- Providence Research Network, Portland, Oregon, USA.
ORCID-Profile: Kristel Lourdault
Förderung
- John Wayne Cancer Foundation
- Borstein Family Foundation
Zitieren
APA
Cowman, A. W., Lourdault, K., Hanes, D., Weiss, J., Nassoiy, S., Goldfarb, M., & Essner, R. (2025). Surgical Management of Thick Primary Cutaneous Melanoma in the US. Cancer Medicine. https://doi.org/10.1002/cam4.70578
Vancouver
Cowman AW, Lourdault K, Hanes D, Weiss J, Nassoiy S, Goldfarb M, et al. Surgical Management of Thick Primary Cutaneous Melanoma in the US. Cancer Medicine. 2025. doi:10.1002/cam4.70578
BibTeX
@article{Cowman2025,
author = {Cowman, Arthur W and Lourdault, Kristel and Hanes, Douglas and Weiss, Jessica and Nassoiy, Sean and Goldfarb, Melanie and Essner, Richard},
title = {Surgical Management of Thick Primary Cutaneous Melanoma in the US},
journal = {Cancer Medicine},
year = {2025},
doi = {10.1002/cam4.70578}
}
EUVIMED